CoChat

Deletion of galectin‐3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1G93A mouse model of amyotrophic lateral sclerosis

Open access
Lerman, Bruce J., Hoffman, Eric P., Sutherland, Margaret L., Bouri, Khaled, Hsu, Daniel K., Liu, Fu‐Tong, Rothstein, Jeffrey D., Knoblach, Susan M. · 2012 · Brain and Behavior
Cited by 88

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Galectins are pleiotropic carbohydrate‐binding lectins involved in inflammation, growth/differentiation, and tissue remodeling. The functional role of galectins in amyotrophic lateral sclerosis (ALS) is unknown. Expression studies revealed increases in galectin‐1 mRNA and protein in spinal cords from SOD1 G93A mice, and in galectin‐3 and ‐9 mRNAs and proteins in spinal cords of both SOD1 G93A mice and sporadic ALS patients. As the increase in galectin‐3 appeared in early presymptomatic stages and increased progressively through to end stage of disease in the mouse, it was selected for additional study, where it was found to be mainly expressed by microglia. Galectin‐3 antagonists are not selective and do not readily cross the blood–brain barrier; therefore, we generated SOD1 G93A/Gal‐3 −/− transgenic mice to evaluate galectin‐3 deletion in a widely used mouse model of ALS. Disease progression, neurological symptoms, survival, and inflammation were assessed to determine the effect of galectin‐3 deletion on the SOD1 G93A disease phenotype. Galectin‐3 deletion did not change disease onset, but resulted in more rapid progression through functionally defined disease stages, more severely impaired neurological symptoms at all stages of disease, and expiration, on average, 25 days earlier than SOD1 G93A/Gal‐3 +/+ cohorts. In addition, microglial staining, as well as TNF‐α, and oxidative injury were increased in SOD1 G93A/Gal‐3 −/− mice compared with SOD1 G93A/Gal‐3 +/+ cohorts. These data support an important functional role for microglial galectin‐3 in neuroinflammation during chronic neurodegenerative disease. We suggest that elevations in galectin‐3 by microglia as disease progresses may represent a protective, anti‐inflammatory innate immune response to chronic motor neuron degeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/brb3.75

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 88

Metadata

Authors
Lerman, B. J., Hoffman, E. P., Sutherland, M. L., Bouri, K., Hsu, D. K., Liu, F., Rothstein, J. D., & Knoblach, S. M.
Venue
Brain and Behavior
Publisher
Wiley
Published
2012-07-23
Volume
2
Issue
5
Pages
563-575
ISSN
  • 2157-9032 (ISSN-L)
  • 2162-3279
OpenAlex
W2028298072
Cited by
88
References
7
FWCI
3.55
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.